rs11568666
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_005845.5(ABCC4):c.2100C>T(p.Ala700Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00755 in 1,614,150 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0058 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0077 ( 61 hom. )
Consequence
ABCC4
NM_005845.5 synonymous
NM_005845.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.438
Publications
7 publications found
Genes affected
ABCC4 (HGNC:55): (ATP binding cassette subfamily C member 4 (PEL blood group)) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This family member plays a role in cellular detoxification as a pump for its substrate, organic anions. It may also function in prostaglandin-mediated cAMP signaling in ciliogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2014]
ABCC4 Gene-Disease associations (from GenCC):
- qualitative platelet defectInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 13-95164453-G-A is Benign according to our data. Variant chr13-95164453-G-A is described in ClinVar as Benign. ClinVar VariationId is 779444.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.438 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABCC4 | NM_005845.5 | c.2100C>T | p.Ala700Ala | synonymous_variant | Exon 16 of 31 | ENST00000645237.2 | NP_005836.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABCC4 | ENST00000645237.2 | c.2100C>T | p.Ala700Ala | synonymous_variant | Exon 16 of 31 | NM_005845.5 | ENSP00000494609.1 |
Frequencies
GnomAD3 genomes AF: 0.00583 AC: 887AN: 152208Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
887
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00688 AC: 1728AN: 251270 AF XY: 0.00713 show subpopulations
GnomAD2 exomes
AF:
AC:
1728
AN:
251270
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00772 AC: 11292AN: 1461824Hom.: 61 Cov.: 31 AF XY: 0.00790 AC XY: 5745AN XY: 727210 show subpopulations
GnomAD4 exome
AF:
AC:
11292
AN:
1461824
Hom.:
Cov.:
31
AF XY:
AC XY:
5745
AN XY:
727210
show subpopulations
African (AFR)
AF:
AC:
30
AN:
33480
American (AMR)
AF:
AC:
124
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
752
AN:
26134
East Asian (EAS)
AF:
AC:
0
AN:
39684
South Asian (SAS)
AF:
AC:
965
AN:
86258
European-Finnish (FIN)
AF:
AC:
205
AN:
53418
Middle Eastern (MID)
AF:
AC:
57
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
8600
AN:
1111964
Other (OTH)
AF:
AC:
559
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
546
1091
1637
2182
2728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00583 AC: 888AN: 152326Hom.: 5 Cov.: 32 AF XY: 0.00583 AC XY: 434AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
888
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
434
AN XY:
74484
show subpopulations
African (AFR)
AF:
AC:
56
AN:
41574
American (AMR)
AF:
AC:
51
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
108
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
63
AN:
4826
European-Finnish (FIN)
AF:
AC:
19
AN:
10618
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
532
AN:
68028
Other (OTH)
AF:
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
49
99
148
198
247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 28, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.